Poland· PL-100127648
Yentreve
A duloxetine product containing duloxetinum, registered in Poland by Eli Lilly Nederland B.V.. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Duloxetine is registered in 16 of 19 countries.
Countries holding a registration under ATC N06AX21 (duloxetine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Duloxetine · ATC N06AX21
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of duloxetine costs, country by country.
Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.28 in United States to $1.57 in Switzerland — a ×5.6 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Duloxetine · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.57
- IT Italy$0.67
- US United States$0.28 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Duloxetinum
- Manufacturer
- Eli Lilly Nederland B.V.
- Country
- Poland (PL)
- ATC code
- N06AX21
- ATC class
- Duloxetine
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
- gtin05909990009688
- gtin05909990009695
- gtin05909990009701
- gtin05909990009749
- gtin05909990009756
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
501 interactions on record for duloxetine.
Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Duloxetine · interactions on record
501 records
- 33 severe
- 247 moderate
- 23 minor
- 130 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
68 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Duloxetine in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDuloxetine 40mg gastro-resistant capsulesA A H Pharmaceuticals Ltd
- United StatesDRIZALMA SPRINKLESUN PHARMACEUTICAL INDUSTRIES, INC.
- SwedenDuloxetin Actavis 40 mg Enterokapsel, hårdActavis Group PTC ehf.
- NetherlandsDuloxetine Sandoz 40 mg, maagsapresistente harde capsulesSandoz B.V.
- FinlandDuloxetin StadaSTADA Arzneimittel AG
- BelgiumAriclaim 40 mgEli Lilly Nederland
- SpainYENTREVE 40 mg CAPSULAS DURAS GASTRORRESISTENTESEli Lilly Nederland B.V.
- IcelandYentreveEli Lilly Nederland B.V.*
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Dulasolan, Duloxetin +pharma
- Belgium · Duloxetin Ab, Duloxétine Ab
- Bulgaria · Dulasolan, Duxet
- Cyprus · Dulox, Duloxetine Accord
- Czechia · Dolyxan, Dulasolan
- Germany · Dulasolan, Duloxalta
- Denmark · Aritavi, Duciltia
- Estonia · Dulsevia, Onelar
- Spain · Dedulox 30 Mg Cápsulas Duras Gastrorresistentes Efg, Dedulox 60 Mg
- Finland · Duloxetin Stada, Duloxetine Accord
- France · Duloxetine Accord, Duloxetine Almus
- United Kingdom (Northern Ireland) · Depalta, Duciltia
- Greece · Duciltia, Duloxetine Liconsa
- Croatia · Dolyxan, Duloksetin Pliva
- Hungary · Duciltia, Dulodet
- Ireland · Duloxetine Accord, Duloxetine Clonmel
- Iceland · Aritavi, Cymbalta
- Italy · Alikres, Dulex
- Liechtenstein · Cymbalta, Duloxetine Lilly
- Lithuania · Dulsevia
- Luxembourg · Duloxetin Ab, Duloxetine Liconsa
- Latvia · Dulsevia
- Malta · Onelar
- Netherlands · Dulasolan, Dulodet
- Norway · Cymbalta, Duloxetin Krka
- Portugal · Duloxetina Alter, Duloxetina Amperlem
- Romania · Dozzex, Duloxetină Dr. Reddy's
- Sweden · Aritavi, Dulmis
- Slovenia · Duloksetin Sandoz, Dulsevia
- Slovakia · Duloxetin Krka, Duloxetin Krka, D.D., Novo Mesto
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c3044082-52c9-4244-9651-958af8a49604 GET /v1/drugs/c3044082-52c9-4244-9651-958af8a49604?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki dojelitowe, twarde",
"source": "urpl",
"strength": "40 mg",
"packaging": "05909990009688 ¦ Rp ¦ EU/1/04/280/002 ¦ 24404\n28 kaps.\n05909990009695 ¦ Rp ¦ EU/1/04/280/003 ¦ 24405\n56 kaps.\n05909990009701 ¦ Rp ¦ EU/1/04/280/004 ¦ 24406\n98 kaps.\n05909990009749 ¦ Rp ¦ EU/1/04/280/005 ¦ 24407\n140 kaps.\n05909990009756 ¦ Rp ¦ EU/1/04/280/006 ¦ 24408\n196 kaps.",
"substance": "Duloxetinum 40 mg",
"common_name": "Duloxetinum",
"pl_product_id": "100127648",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about duloxetine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.